C-reactive protein levels in schizophrenia: A review and meta-analysis

Brian J Miller, Nick Culpepper, Mark H. Rapaport

Research output: Contribution to journalReview article

103 Citations (Scopus)

Abstract

There is an impression in the literature that schizophrenia is associated with increased inflammation, including abnormal blood levels of the acute phase reactant C-reactive protein (CRP). We performed a meta-analysis of blood CRP levels to estimate the overall effect size, as well as a pooled analysis of the prevalence of an elevated CRP level in patients with schizophrenia and related disorders. We identified articles by searching PubMed, PsycInfo, and ISI, and the reference lists of identified studies. Eight studies met the inclusion criteria for the meta-analysis, and five studies were included in the pooled analysis. CRP levels were significantly increased in patients compared to controls (effect size=0.45, 95% confidence interval 0.34-0.55, p<0.001). There was a 28% prevalence of an elevated CRP level in patients with schizophrenia and related disorders. Our results support a growing body of literature that schizophrenia is associated with increased inflammation, although many studies did not control for potential confounding factors such as BMI and smoking. Given the high prevalence of elevated CRP, metabolic syndrome, and premature cardiovascular mortality, our findings also suggest that measurement of blood CRP levels may be germane to the clinical care of patients with schizophrenia and related disorders.

Original languageEnglish (US)
Pages (from-to)223-230
Number of pages8
JournalClinical Schizophrenia and Related Psychoses
Volume7
Issue number4
DOIs
StatePublished - Jan 1 2014

Fingerprint

C-Reactive Protein
Meta-Analysis
Schizophrenia
Blood Proteins
Metabolic Syndrome X
Inflammation
Premature Mortality
Acute-Phase Proteins
PubMed
Patient Care
Smoking
Confidence Intervals

Keywords

  • CRP
  • Meta-Analysis
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

C-reactive protein levels in schizophrenia : A review and meta-analysis. / Miller, Brian J; Culpepper, Nick; Rapaport, Mark H.

In: Clinical Schizophrenia and Related Psychoses, Vol. 7, No. 4, 01.01.2014, p. 223-230.

Research output: Contribution to journalReview article

@article{92014f893b6c45168ebdcd86221a18aa,
title = "C-reactive protein levels in schizophrenia: A review and meta-analysis",
abstract = "There is an impression in the literature that schizophrenia is associated with increased inflammation, including abnormal blood levels of the acute phase reactant C-reactive protein (CRP). We performed a meta-analysis of blood CRP levels to estimate the overall effect size, as well as a pooled analysis of the prevalence of an elevated CRP level in patients with schizophrenia and related disorders. We identified articles by searching PubMed, PsycInfo, and ISI, and the reference lists of identified studies. Eight studies met the inclusion criteria for the meta-analysis, and five studies were included in the pooled analysis. CRP levels were significantly increased in patients compared to controls (effect size=0.45, 95{\%} confidence interval 0.34-0.55, p<0.001). There was a 28{\%} prevalence of an elevated CRP level in patients with schizophrenia and related disorders. Our results support a growing body of literature that schizophrenia is associated with increased inflammation, although many studies did not control for potential confounding factors such as BMI and smoking. Given the high prevalence of elevated CRP, metabolic syndrome, and premature cardiovascular mortality, our findings also suggest that measurement of blood CRP levels may be germane to the clinical care of patients with schizophrenia and related disorders.",
keywords = "CRP, Meta-Analysis, Schizophrenia",
author = "Miller, {Brian J} and Nick Culpepper and Rapaport, {Mark H.}",
year = "2014",
month = "1",
day = "1",
doi = "10.3371/CSRP.MICU.020813",
language = "English (US)",
volume = "7",
pages = "223--230",
journal = "Clinical Schizophrenia and Related Psychoses",
issn = "1935-1232",
publisher = "Walsh Medical Media, LLC",
number = "4",

}

TY - JOUR

T1 - C-reactive protein levels in schizophrenia

T2 - A review and meta-analysis

AU - Miller, Brian J

AU - Culpepper, Nick

AU - Rapaport, Mark H.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - There is an impression in the literature that schizophrenia is associated with increased inflammation, including abnormal blood levels of the acute phase reactant C-reactive protein (CRP). We performed a meta-analysis of blood CRP levels to estimate the overall effect size, as well as a pooled analysis of the prevalence of an elevated CRP level in patients with schizophrenia and related disorders. We identified articles by searching PubMed, PsycInfo, and ISI, and the reference lists of identified studies. Eight studies met the inclusion criteria for the meta-analysis, and five studies were included in the pooled analysis. CRP levels were significantly increased in patients compared to controls (effect size=0.45, 95% confidence interval 0.34-0.55, p<0.001). There was a 28% prevalence of an elevated CRP level in patients with schizophrenia and related disorders. Our results support a growing body of literature that schizophrenia is associated with increased inflammation, although many studies did not control for potential confounding factors such as BMI and smoking. Given the high prevalence of elevated CRP, metabolic syndrome, and premature cardiovascular mortality, our findings also suggest that measurement of blood CRP levels may be germane to the clinical care of patients with schizophrenia and related disorders.

AB - There is an impression in the literature that schizophrenia is associated with increased inflammation, including abnormal blood levels of the acute phase reactant C-reactive protein (CRP). We performed a meta-analysis of blood CRP levels to estimate the overall effect size, as well as a pooled analysis of the prevalence of an elevated CRP level in patients with schizophrenia and related disorders. We identified articles by searching PubMed, PsycInfo, and ISI, and the reference lists of identified studies. Eight studies met the inclusion criteria for the meta-analysis, and five studies were included in the pooled analysis. CRP levels were significantly increased in patients compared to controls (effect size=0.45, 95% confidence interval 0.34-0.55, p<0.001). There was a 28% prevalence of an elevated CRP level in patients with schizophrenia and related disorders. Our results support a growing body of literature that schizophrenia is associated with increased inflammation, although many studies did not control for potential confounding factors such as BMI and smoking. Given the high prevalence of elevated CRP, metabolic syndrome, and premature cardiovascular mortality, our findings also suggest that measurement of blood CRP levels may be germane to the clinical care of patients with schizophrenia and related disorders.

KW - CRP

KW - Meta-Analysis

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84892623490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892623490&partnerID=8YFLogxK

U2 - 10.3371/CSRP.MICU.020813

DO - 10.3371/CSRP.MICU.020813

M3 - Review article

C2 - 23428789

AN - SCOPUS:84892623490

VL - 7

SP - 223

EP - 230

JO - Clinical Schizophrenia and Related Psychoses

JF - Clinical Schizophrenia and Related Psychoses

SN - 1935-1232

IS - 4

ER -